<?xml version="1.0" encoding="UTF-8"?>
<urlset xmlns="http://www.sitemaps.org/schemas/sitemap/0.9" xmlns:image="http://www.google.com/schemas/sitemap-image/1.1">
  <url>
    <loc>https://vaayath.com/blog</loc>
    <lastmod>2026-09-09</lastmod>
    <changefreq>daily</changefreq>
  </url>
  <url>
    <loc>https://vaayath.com/blog/200</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/114.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=fa01e2d3326e67796456d9b8451c0281c3a2a8befaeb347f4a4886732fca34f4</image:loc>
      <image:title>CDSCO Adds European Union to Rule 63's Recognised Jurisdictions, Tightens Class A NSNM Self-Certification</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/199</loc>
    <lastmod>2026-08-27</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/113.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=c6e5f576c93735a944bc91dacfe9c66ef3e1e70049e35a58ed606f3f8a7509d4</image:loc>
      <image:title>CDSCO Introduces Ninth Schedule Testing Fees and Mandatory Sterilization Site Labeling</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/198</loc>
    <lastmod>2026-08-25</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/112.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=ae0040169f7e66154bce7d54af5cdebb5b3cab6b607d75cf0c033258999da126</image:loc>
      <image:title>CDSCO Extends Pediatric Warning to All Chlorpheniramine and Phenylephrine FDCs</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/197</loc>
    <lastmod>2026-08-24</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/111.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=9a16bc02ac2a2026bf7b4a6e2e63c340698b63cc8e2c86978b7b640925f57276</image:loc>
      <image:title>Schedule H1 Set to Add Flupentixol, Zopiclone, Gabapentin and Carisoprodol: What G.S.R. 745(E) Proposes</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/196</loc>
    <lastmod>2026-08-13</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/110.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=a5edc4575cfd507b5006994c82e83097395be19326950f1216eeaaf3ec56fa6e</image:loc>
      <image:title>CDSCO Flags Enclomiphene as an Unapproved New Drug — Manufacturing and Marketing Under Scanner</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/195</loc>
    <lastmod>2026-08-12</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/109.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=c9891c7c3c57ffc8c6bac3eaff6e067d8483ac7ed0119a0818db02ca62cd9fbb</image:loc>
      <image:title>CDSCO Directs IND Division to Process Import Permission for New Drugs Backed by Ongoing Phase III Global Clinical Trials</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/194</loc>
    <lastmod>2026-08-11</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/108.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=c943a58a95ad73e1a59824805d25c5ad4676f9107ac44c02a3b0c4cd02b1bb2d</image:loc>
      <image:title>Drugs (Twelfth Amendment) Rules, 2026: CDSCO Widens Form 29 Licence Categories Under Rule 89</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/193</loc>
    <lastmod>2026-08-08</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/104.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=e23e880bd29a85f601bd870c86bab20c23ba5a69077a413aa7b5333bfa3dd223</image:loc>
      <image:title>India introduces formal debarment for false or fabricated documents in drug licensing</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/192</loc>
    <lastmod>2026-08-06</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/103.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=62119059693fde15a6a0ef70de948f970e2b61cd0fb228291ff4f87d8b4290fe</image:loc>
      <image:title>CDSCO’s Revised Guidance on Common Submission Format for Import &amp; Registration of Drugs: What Changed in 2026</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/191</loc>
    <lastmod>2026-08-05</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/102.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=9228f8af2e07f5a3209677fe8162f0014f052a7ca6d76dc05339b09bd30e39b9</image:loc>
      <image:title>DPCO (Amendment) Order, 2026: Overcharging Liability Relief for Pharma manufacturers</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/190</loc>
    <lastmod>2026-07-31</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/101.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=9743b93458af21f85203d5f79409a05e8e85782672605cc9cb06c61e34b284e0</image:loc>
      <image:title>CDSCO Directs Ibuprofen Manufacturers to Add 'Fixed Drug Eruption' to Prescribing Information Leaflets</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/189</loc>
    <lastmod>2026-07-24</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/100.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=7e2bb0339136555d886b9578afbba85351cd9d07fa79b55889619e27c095445f</image:loc>
      <image:title>No Registration Certificate, No Entry for Imported Cosmetics</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/188</loc>
    <lastmod>2026-07-23</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/99.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=e687fae4ccd05e6d52a40afe620f12c4c0f9bd759e981bb1c9eaf9cbe04415c9</image:loc>
      <image:title>CDSCO Clarifies Jurisdiction for Compounding of Offences Applications</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/187</loc>
    <lastmod>2026-07-22</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/98.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=f2859dab47db750e3bc86a2e174fb3a89153a0f46856081a75bcb9a7e7db4e13</image:loc>
      <image:title>CDSCO Notifies Final Guidance Document on Medical Device Software (MDSW)</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/186</loc>
    <lastmod>2026-07-17</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/97.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=7a98de29a7536b8956ab0cb442528849b702ff358ea9e4f85f0d56863b64387c</image:loc>
      <image:title>When a “+” Sign Isn’t Just a Plus</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/185</loc>
    <lastmod>2026-07-11</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/96.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=433205136a5080d0d1cc35f799abb0a7ec59a71ceeb7d893a56ca672e5ef2a8c</image:loc>
      <image:title>DCC intends to tighten control on manufacturing and supply of printed packaging materials used for drugs</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/184</loc>
    <lastmod>2026-07-10</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/95.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=3572a48527432ea5eb7aea22cda2ae44c64327c5872a2da7ba6c058b8a8a0281</image:loc>
      <image:title>High-Alcohol Oral Formulations Move Into Schedule H1</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/183</loc>
    <lastmod>2026-07-08</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/94.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=1c53a437d6d9dfc4246a872aa12189707d781efa0ef18b2ea3e6ca62fff7d5b8</image:loc>
      <image:title>DCC Recommends Mandatory Public Disclosure of Suspended and Cancelled Drug Licenses</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/182</loc>
    <lastmod>2026-07-04</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/93.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=a0e0bd151978a4f76fc1b566bf4aae735e62b97a6e06421db70107eed9a653bd</image:loc>
      <image:title>D&amp;C Amended to Cover Licensing of Stem Cell Products, Gene Therapeutics and Xenografts</image:title>
    </image:image>
  </url>
  <url>
    <loc>https://vaayath.com/blog/181</loc>
    <lastmod>2026-06-27</lastmod>
    <changefreq>weekly</changefreq>
    <image:image>
      <image:loc>https://pharmainfo.s3.ap-south-1.amazonaws.com/pharma-Blogs/107.png?X-Amz-Security-Token=IQoJb3JpZ2luX2VjEKP%2F%2F%2F%2F%2F%2F%2F%2F%2F%2FwEaCmFwLXNvdXRoLTEiSDBGAiEArSXaLmiywrgwzvH28Vsz8cJtkPROqz7lCTatPmfjRKkCIQCHaurz%2B%2FkMZCFj8AKwITJwTG8MmKt8YC5oQCrRBj1hHyrABQhsEAAaDDIxODQ5Njg0NTc2NSIMgT%2BvuWlmgKlxQ8%2FBKp0FDxHvojjKY1s0PYtumBbrEhxMcLjadqjZOKIgM0NPphsGlKrH7jtBV%2FVAvzH9BtyC0ucw118%2FxoPrdbApiKyb%2BtIYQLskdQjCt8Nn9v2OcIY%2FeMfKiFJeJjNacZCUCgu5ZZ3clVW0FXVMpcaGMYcEcdTlYt3VPpPeFGJtYveyT6HaWHssyyhSRtbWl4hnq7Q696SEzwWK5YD9lUOhtrgC%2FZf8S5WkQYPLuC02g8aEtFkv%2FYoTPZaM32ZYpIrTJDLzjKMCLKhyZMJafihAaZgddl%2FtvWPoU9cJCTZXTABAoNopsW2MkGmSh1MkYWVGBpEQiLgM0bm84NA%2BckeWaG%2B11r2fPHCZcA3FVTu4KH4uYO0PNaYgCq%2BM%2FhEAN6sUokXayCnJuNKjSy0U4AWPr7eJo3IzXIQB%2B3n%2BUwcqMqOkRaBfZQuYsSoEmhlT2WWuSu1hH%2F%2BHT1CsaFsbjOouVjA9u9E9APGMPubCobdHajtVs0Gg3eKwXmlH5pBIW1fTaEENk4nVlv27q2xtOzJbwCdqqoyWq%2BsYvtxmAjEvK4fitNZxNkJe2s%2FL35XdQCIiTDK7DqRTBgGagligjrsAblurRHM46y7yosjixfJD7Vi4Eq2ymN2xlqbaOkENIctxVGHJMsgjIgtoHizU7lxjpPMOAdVI%2BLV64dTfGSmLIhSzj%2Fg7K5m36fdQALreIqAliP7Y83lQ50BV3PfgZOcw3v1aXJ%2FExCp%2F8BYSTb3tjakMzKl8iyrvMwlN9OjfiLo9LyOHbd3IDTu7va9W%2FhKJR8nQkeQBzz3tc5mFb%2FQJF1Xt0faBoVXhd%2BO5HJ%2FPVACgH%2BBxk2dqQv19XmSVk%2F9UvaaPRV3eETX3a09Ad30TGkxaEEMAPL5Y80o%2BOfdD%2FrYVMP%2FshNUGOrAB%2BjVywMvTbatXpV0sr6PoDac5meGddrBJR4hmERwyMYLac0IpMgFm1BIdFE3nBYAlBzsTtOGSXTjVvU9lNlwu0xVlXBifHYMMeKwUm8%2BG%2BBWQTlShNE8PdZF%2F%2BiEdsvAseev1lQR41Q7eEwAgHAANRwwjVYEq6jSIoLTSGV8MAgsRiUVEuRxAaPHEulrweuQ%2FZfc7ImBsf7%2BKlU2iC8Mkhs6d6tcC8ca%2Bf5x2toaNV%2F8%3D&amp;X-Amz-Algorithm=AWS4-HMAC-SHA256&amp;X-Amz-Date=20260909T132319Z&amp;X-Amz-SignedHeaders=host&amp;X-Amz-Credential=ASIATFX3NI7CQSWFMUBG%2F20260909%2Fap-south-1%2Fs3%2Faws4_request&amp;X-Amz-Expires=86400&amp;X-Amz-Signature=67002ebf2761b17c26489144c2a32beb876d05efcfe95ac4ad0721aed5026b92</image:loc>
      <image:title>Schedule H2 Expanded: Antimicrobials and Many Other Drugs Now Under Stricter Controls</image:title>
    </image:image>
  </url>
</urlset>
